New findings published in the journal Science Translational Medicine reveal that a simple blood test may be helpful in detecting the possible relapse of early stage breast cancer that has already been treated, identifying tumors up to eight months before they would even show up on medical scans.
New findings published in JAMA Oncology reveal that some women are more susceptible to rare early breast cancer. This typically included younger black women who had a greater chance of being diagnosed with ductal carcinoma in situ, otherwise known as DCIS. Furthermore, early diagnosis and treatment ...
Researchers have discovered a molecule present in basal-like breast cancer, or BLBC, tumors that allows them to be detected, and when its presence was reduced in cancer cell models the tumors' growth was slowed significantly.
New findings published in the journal Cancer Epidemiology, Biomarkers and Prevention reveal that breast cancer survivors may be more likely to gain weight than cancer-free counterparts.
Researchers at Lund University have linked low levels of the hormone enkephaline to an increased risk of breast cancer in women--a hormone comprised of pain and anxiety-reducing properties that reinforces the immune system by directly affecting immune cells.
Previous studies have discussed the dangers of prolonged sitting. Yet now, new findings published in the journal Cancer Epidemiology, Biomarkers and Prevention reveal that women who sit for extended periods of time may be at an increased risk of breast cancer.
New findings published in the journal Nature reveal that the common female hormone progesterone may boost the lifespan of breast cancer patients.
Could removing a protein help slow blood vessel growth in tumors?
New findings published in the Journal of Clinical Endocrinology & Metabolism elaborate on the dangers of pesticide dichlorodiphenyltrichloroethane (DDT) and breast cancer risk. Though the chemical was banned in the United States nearly 42 years ago, scientists are still examining its connection to h...
New findings published in the journal Laboratory Investigation investigate how this medication may fight off cancer stem cell reproduction that can lead to relapse in some patients.
Scientists may have uncovered a key to preventing secondary cancers in breast cancer patients.